Lilly drops edivoxetine for MDD

Eli Lilly and Co. (NYSE:LLY) discontinued development of edivoxetine ( LY2216684) as adjunctive treatment for major depressive disorder (MDD) after once-daily oral edivoxetine as an add-on to a select...